Literature DB >> 25408372

Identification of differently expressed genes with specific SNP Loci for breast cancer by the integration of SNP and gene expression profiling analyses.

Pengfei Yuan1, Dechun Liu, Miao Deng, Jiangbo Liu, Jianguang Wang, Like Zhang, Qipeng Liu, Ting Zhang, Yanbin Chen, Gaoyuan Jin.   

Abstract

This study aims to explore the relationship between gene polymorphism and breast cancer, and to screen DEGs (differentially expressed genes) with SNPs (single nucleotide polymorphisms) related to breast cancer. The SNPs of 17 patients and the preprocessed SNP profiling GSE 32258 (38 cases of normal breast cells) were combined to identify their correlation with breast cancer using chi-square test. The gene expression profiling batch8_9 (38 cases of patients and 8 cases of normal tissue) was preprocessed with limma package, and the DEGs were filtered out. Then fisher's method was applied to integrate DEGs and SNPs associated with breast cancer. With NetBox software, TRED (Transcriptional Regulatory Element Database) and UCSC (University of California Santa Cruz) database, genes-associated network and transcriptional regulatory network were constructed using cytoscape software. Further, GO (Gene Ontology) and KEGG analyses were performed for genes in the networks by using siggenes. In total, 332 DEGs were identified. There were 160 breast cancer-related SNPs related to 106 genes of gene expression profiling (19 were significant DEGs). Finally, 11co-correlated DEGs were selected. In genes-associated network, 9 significant DEGs were correlated to 23 LINKER genes while, in transcriptional regulatory network, E2F1 had regulatory relationships with 7 DEGs including MTUS1, CD44, CCNB1 and CCND2. KRAS with SNP locus of rs1137282 was involved in 35 KEGG pathways. The genes of MTUS1, CD44, CCNB1, CCND2 and KRAS with specific SNP loci may be used as biomarkers for diagnosis of breast cancer. Besides, E2F1 was recognized as the transcription factor of 7 DEGs including MTUS1, CD44, CCNB1 and CCND2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25408372     DOI: 10.1007/s12253-014-9851-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  35 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  The paradox of E2F1: oncogene and tumor suppressor gene.

Authors:  D G Johnson
Journal:  Mol Carcinog       Date:  2000-03       Impact factor: 4.784

3.  Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach.

Authors:  M C Whitlock
Journal:  J Evol Biol       Date:  2005-09       Impact factor: 2.411

4.  Breast cancer in the young patient.

Authors:  Jack Sariego
Journal:  Am Surg       Date:  2010-12       Impact factor: 0.688

5.  Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.

Authors:  Wen-Yi Wang; Yi-Chih Chien; Yong-Kie Wong; Yan-Liang Lin; Jin-Ching Lin
Journal:  Head Neck       Date:  2011-06-17       Impact factor: 3.147

6.  Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe.

Authors:  Milena Sant; Claudia Allemani; Riccardo Capocaccia; Timo Hakulinen; Tiiu Aareleid; Jan Willem Coebergh; Michel P Coleman; Pascale Grosclaude; Carmen Martinez; Janine Bell; Judith Youngson; Franco Berrino
Journal:  Int J Cancer       Date:  2003-09-01       Impact factor: 7.396

7.  Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.

Authors:  Hui Ye; Nisa Pungpravat; Bau-Lin Huang; Lorenzo L Muzio; Maria A Mariggiò; Zugen Chen; David T Wong; Xiaofeng Zhou
Journal:  Cancer Genet Cytogenet       Date:  2007-07-15

8.  Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.

Authors:  Andrea Veronesi; Clelia de Giacomi; Maria D Magri; Davide Lombardi; Martina Zanetti; Cristina Scuderi; Riccardo Dolcetti; Alessandra Viel; Diana Crivellari; Ettore Bidoli; Mauro Boiocchi
Journal:  BMC Cancer       Date:  2005-07-04       Impact factor: 4.430

9.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

10.  Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.

Authors:  Kristy E Driver; Honglin Song; Fabienne Lesueur; Shahana Ahmed; Nuno L Barbosa-Morais; Jonathan P Tyrer; Bruce A J Ponder; Douglas F Easton; Paul D P Pharoah; Alison M Dunning
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

View more
  4 in total

1.  KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.

Authors:  I Sullivan; J Salazar; C Arqueros; M Andrés; A Sebio; M Majem; J Szafranska; E Martínez; D Páez; A López-Pousa; M Baiget; A Barnadas
Journal:  Clin Transl Oncol       Date:  2017-02-01       Impact factor: 3.405

2.  Multiple correlation analyses revealed complex relationship between DNA methylation and mRNA expression in human peripheral blood mononuclear cells.

Authors:  Fang-Fei Xie; Fei-Yan Deng; Long-Fei Wu; Xing-Bo Mo; Hong Zhu; Jian Wu; Yu-Fan Guo; Ke-Qin Zeng; Ming-Jun Wang; Xiao-Wei Zhu; Wei Xia; Lan Wang; Pei He; Peng-Fei Bing; Xin Lu; Yong-Hong Zhang; Shu-Feng Lei
Journal:  Funct Integr Genomics       Date:  2017-07-22       Impact factor: 3.410

Review 3.  Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer.

Authors:  Maria M Haykal; Sylvie Rodrigues-Ferreira; Clara Nahmias
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

4.  Impact of a Eukaryotic Translation Initiation Factor 3a Polymorphism on Susceptibility to Gastric Cancer.

Authors:  Kuijie Liu; Zhendong Lei; Hongliang Yao; Sanlin Lei; Hua Zhao
Journal:  Med Princ Pract       Date:  2016-06-22       Impact factor: 1.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.